COMMUNIQUÉS West-GlobeNewswire

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors
13/02/2024
CINCINNATI, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics [...]
RadNet, Inc. Announces Date of its Fourth Quarter 2023 Financial Results Conference Call
13/02/2024
LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
13/02/2024
AUSTIN, TX and DURHAM, NC, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new [...]
Immuron achieves record Travelan® sales
13/02/2024
Highlights: Travelan ® sales YTD Jan 2024 of $2.7 million exceed peak full year FY20 sales of $2.5 million Australian Travelan ® YTD Jan 2024 sales $2.1 million USA Travelan ® YTD Jan 2024 sales $0.6 million Canadian [...]
Notice to the Annual General Meeting of Orion Corporation
13/02/2024
ORION CORPORATION STOCK EXCHANGE RELEASE / NOTICE TO GENERAL MEETING 13 FEBRUARY 2024 at 12:15 EET Notice to the Annual General Meeting of Orion Corporation Notice is given to the shareholders of Orion Corporation of [...]
Orion Group Financial Statement Release January–December 2023
13/02/2024
ORION CORPORATION FINANCIAL STATEMENT RELEASE 1-12/2023 13 FEBRUARY 2024 at 12:00 EET Orion Group Financial Statement Release January–December 2023 Net sales totalled EUR 1,189.7 (January–December 2022: 1,340.6) million [...]
Anocca Appoints Martin Welschof to Board of Directors
13/02/2024
SÖDERTÄLJE, Sweden, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Anocca AB, a leading TCR-T 1 cell therapy company, today announced the appointment of Martin Welschof to its Board of Directors. Martin Welschof is currently CEO of [...]
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)
13/02/2024
— Over 8,000 patients 12 years of age and older with severe SCD or TDT may be eligible for treatment — ZUG, Switzerland and BOSTON, Feb. 13, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a [...]
Myocene Got ISO 13485 Medical-Grade Certification
13/02/2024
LIÈGE, Belgium, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Myocene, the Belgian-based sportstech company, has successfully obtained from a Notified Body the ISO 13485 certification for its quality management system. Myocene is a [...]
PanTera signs agreement with Bayer for the supply of actinium-225
13/02/2024
Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients Mol, Belgium, February 13, 2023: PanTera, the Belgian joint venture created [...]
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2023
13/02/2024
Tokyo, Japan and Cambridge, UK, 13 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the 12 [...]
Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio
13/02/2024
Increased Cresemba ® and Zevtera ® -related revenue of CHF 150.3 million (+22.9% year-on-year) at upper end of guidance Operating profit of CHF 19.2 million and net profit of CHF 10.5 million, significantly above [...]
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
12/02/2024
James Huang brings over 30 years of biotech experience as a successful entrepreneur, investor and key opinion leader in the healthcare sector SAN DIEGO, CA and TAICANG, China, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Connect [...]
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
12/02/2024
Enhances availability of device therapy options, particularly for those who struggle with single pressure PAP therapy Part of Air11 Solutions, key features include Care Check-in, Personal Therapy Assistant, among others [...]
Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia
12/02/2024
Friedreich’s ataxia is a rare, genetic, life-shortening, debilitating, and neurodegenerative disorder Treatment with SKYCLARYS improved patient function compared to placebo Biogen is leveraging its expertise and [...]
Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
12/02/2024
SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed its underwritten [...]
G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
12/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced that the independent Data Monitoring Committee (DMC) [...]
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
12/02/2024
SAN JOSE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]
Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/02/2024
SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified [...]

Pages